Thrive Capital has closed the largest fund in its history with a $10 billion vehicle that nearly doubles the size of its predecessor. The fund, Thrive X, marks the firm’s 10th fundraise and was oversubscribed, according to industry reports.
Of the total capital, $1 billion is meant for early-stage investments, while $9 billion is allocated to growth-stage companies. But the firm is framing this moment not as a milestone, but as a renewed commitment to the long game.
Backing the builders
Thrive’s philosophy is to focus on concentration rather than diversification. The firm describes its product as a partnership, committing deeply to a small number of founders and standing with them through both momentum and adversity.
“We do not hedge,” the firm said in announcing Thrive X. Exposure alone is not a strategy. Advantage belongs to those who choose deliberately and endure difficult cycles alongside the companies they back.
Founded by Joshua Kushner, Thrive was built with the idea of acting as an enabler rather than the star of the story. Founders are the artists, and Thrive’s role is to create the conditions where meaningful work can flourish.
Riding the AI wave
The long-view approach is now intersecting with one of the most transformative technology shifts in decades. Thrive’s portfolio includes some of the most valuable private companies in the world, such as OpenAI, Stripe, and SpaceX, all of which have seen soaring valuations.
Other notable investments include Databricks, Anduril, and Cursor. Beyond investing, the firm also incubates startups. It has launched 12 companies internally, with at least 6 reaching unicorn status.
Kushner has publicly stated that the eventual winners of the AI boom could be “bigger than we can ever imagine,” noting that the technology remains in its early chapters.
IPO winds and investor patience
The timing of Thrive X also signals something broader. Rumours of potential IPOs, particularly around OpenAI and SpaceX, have intensified. For limited partners waiting on liquidity, those public listings could unlock unprecedented capital returns.
Thrive’s thesis rests on the belief that category-defining companies build structural advantages over long arcs. If even a handful of its marquee bets reach the public markets, the ripple effects could reshape venture capital’s current cycle.
For Thrive, this $10 billion fund is less about scale and more about staying power, a declaration that conviction, not caution, defines its playbook.
